Skip to main content
. 2021 Jun 29;28(5):457–466. doi: 10.1007/s40292-021-00465-7

Table 2.

Real-world treatment adherence based on the number of antihypertensive pills

Variables 1 pill 2 pills 3 pills P value
N. 10551 2500 145
Age (mean (SD)) 73.14 (7.58) 73.31 (7.06) 76.40 (4.76) <0.001
Men (%) 4721 (44.7) 1062 (42.5) 87 (60.0) <0.001
Hospitalized in the past year (%) 1695 (16.1) 458 (18.3) 24 (16.6) 0.039
Adherence (mean (SD)) 73.44 (15.75) 52.95 (11.61) 38.04 (7.79) <0.001
Fully adherent participants (%) 5643 (53.5) 78 (3.1) 0 (0.0) <0.001
BP measurements (mean (SD)) 31.97 (20.41) 36.76 (23.55) 36.28 (18.36) <0.001
Systolic BP, mmHg (mean (SD)) 132.15 (14.30) 134.00 (14.31) 132.52 (14.98) <0.001
Diastolic BP, mmHg (mean (SD)) 75.95 (8.12) 76.18 (8.15) 76.21 (8.56) 0.438
PP, mmHg (mean (SD)) 56.21 (12.53) 57.83 (12.33) 56.30 (13.42) <0.001
Controlled hypertension (%) 7284 (69.0) 1641 (65.6) 102 (70.3) 0.004
No fixed combinations (%) 7795 (73.9) 1870 (74.8) 86 (59.3) <0.001
Fixed-dose double combinations (%) <0.001
 None 7957 (75.4) 1878 (75.1) 86 (59.3)
 1 2594 (24.6) 578 (23.1) 49 (33.8)
 2 0 (0.0) 44 (1.8) 10 (6.9)
Fixed-dose triple combination (%) 162 (1.5) 10 (0.4) 1 (0.7) <0.001
Active ingredients in therapy (mean (SD)) 1.28 (0.48) 2.27 (0.50) 3.49 (0.66) <0.001
ACE inhibitors (%) <0.001
 0 7313 (69.3) 1494 (59.8) 50 (34.5)
 1 3238 (30.7) 863 (34.5) 62 (42.8)
 2 0 (0.0) 143 (5.7) 29 (20.0)
 3 0 (0.0) 0 (0.0) 4 (2.8)
Beta blockers (%) <0.001
 0 8345 (79.1) 1577 (63.1) 45 (31.0)
 1 2206 (20.9) 822 (32.9) 61 (42.1)
 2 0 (0.0) 101 (4.0) 37 (25.5)
 3 0 (0.0) 0 (0.0) 2 (1.4)
Calcium channel blockers (%) <0.001
 0 8090 (76.7) 1541 (61.6) 86 (59.3)
 1 2461 (23.3) 847 (33.9) 52 (35.9)
 2 0 (0.0) 112 (4.5) 7 (4.8)
Diuretics (%) <0.001
 0 7951 (75.4) 1186 (47.4) 62 (42.8)
 1 2511 (23.8) 1097 (43.9) 62 (42.8)
 2 89 (0.8) 217 (8.7) 20 (13.8)
 3 0 (0.0) 0 (0.0) 1 (0.7)
Angiotensin II receptor blockers (%) <0.001
 0 7676 (72.8) 1654 (66.2) 93 (64.1)
 1 2875 (27.2) 781 (31.2) 42 (29.0)
 2 0 (0.0) 65 (2.6) 10 (6.9)

BP blood pressure, PP pulse pressure, ACE angiotensin converting enzyme